An insightful conversation with Dr. Ajay Swaroop (Chairman, Board of Management and Senior Consultant, Department of ENT, Sir Ganga Ram Hospital) and Dr. Evanka Madan (Associate Professor & Consultant, Department of Biotechnology & Research, Sir Ganga Ram Hospital) on institutional vision, research excellence, and the evolving landscape of modern medicine.
A phenomenal change is being witnessed in the healthcare industry due to breakthrough inventions, new modes of therapies, emergence of many new diseases, and a rising demand for individualistic and evidence-based treatment of patients. Nowadays, functions of healthcare organizations are not limited to the provision of medicine; rather, they also include development of various healthcare facilities that provide health services along with the modernization of scientific research, innovation, and medical education.
Not too long ago, Dr. Ajay Swaroop, the Chairman of the Board of Management at Sir Ganga Ram Hospital in New Delhi, and Dr. Evanka Madan, Senior Scientist in the Department of Biotechnology and Research, took part in a podcast in which they shared their views on two major aspects of the healthcare sector: visionary leadership with respect to healthcare organizations and the growing appreciativeness of scientific research and translational medicine.
The discussion shows how important it is to preserve the heritage of modern healthcare institutions while fulfilling new times’ requirements.
Over decades of operation, Sir Ganga Ram Hospital has established itself as one of the leading hospitals due to its commitment and dedication toward clinical excellence, ethical medical practice, patient-oriented care, and institutional integrity. To maintain this reputation while evolving to meet the future requirements and demands of the medical industry, the hospital has to follow the path of continuous evolution, strategic leadership, and open-mindedness toward new possibilities in medicine.
The vision of the hospital is all about enhancing its clinical capabilities, fostering the adoption of technologies, and ensuring that it is capable of keeping up with any shifts in population demands.
In the present-day context, healthcare requires far more than just the incorporation of new diagnostic technologies, innovative types of medical treatment, and interdisciplinary approaches among various departments, such as ENT department, biotechnology and research department, and other specific surgical disciplines. Therefore, the development of the capabilities of the institution is necessary to ensure advances in quality of care.
Equally important is the recognition that hospitals must function not merely as centres of treatment but also as centres of learning, innovation and knowledge generation. Medical education, research and academic collaborations are important pillars in building a sustainable healthcare ecosystem.
Developing cooperation with universities, academic institutions, and research bodies can extend possibilities for scientific discovery, implementation of clinical innovations, and knowledge transfer. These partnerships considerably widen possibilities for institutions of healthcare to take part in the creation of new diagnostics, treatment options, and evidence-based practices.
The long-term aim is to guarantee that SGRH remains a forward-looking organisation while sticking to the values that contribute to its reputation.
Essential in addition to the institutional framework is the increasing prevalence of biotechnology and translational research in transforming the healthcare sector through the Department of Biotechnology & Research.
Dr. Evanka Madan highlights the significance of integrating fundamental scientific discoveries with actual clinical issues. Although progress in molecular biology, genetics, immunology and biotechnology has broadened our comprehension of disease processes, it is still vital to put these discoveries to effective use in real-life medical practice.
By providing the necessary connection between laboratory research and clinical treatment processes, translational research is capable of greatly contributing to the advancement of knowledge about diseases on molecular and cellular levels.
It can be clearly stated that the future of medicine lies in the shift from traditional disease categorization to understanding disease biology at the individual level. These research techniques can therefore help us grasp the idea of disease diversity, predict therapeutic responses and introduce more personalized medicine.
Equally important is the aspect of multidisciplinary team work. Significant results are obtained in collaborative work of clinicians, biologists, bioinformaticians, molecular scientists and technology professionals.
Practically, the interaction between clinicians and researchers is critical for such fields as oncology, cardiology, infectious diseases and inflammatory conditions, where understanding the mechanisms of disease processes is a step towards new diagnostic options and treatment approaches.
Therefore, it is vital to develop the scientific infrastructure, engage in joint research initiatives, bring young scientists into science and develop university partnerships in order to create successful translational research.
A key take-away from the discussion is that the future of healthcare cannot be determined by relying solely on either clinical practice or scientific research.
The combination of clinical practice and molecular research together with innovative technologies can speed up implementation of research developments into improved healthcare solutions.
Hospitals are the perfect place for this synergy to take place as they possess clinical expertise, patient population, diagnostic facilities, and multidisciplinary specialists who can pose scientifically interesting questions.
At the same time, insights based on research allow clinicians to comprehend the intricacies of diseases and search for new diagnostics and treatment options.
Moreover, collaboration with research institutions strengthens the conditions for the creation of the ecosystem by making it possible to gain cutting-edge knowledge and technologies, develop incredible ideas and implement them into scientific practice.
As medicine progresses toward the use of precision medicine and technology-based healthcare, institutions have to invest in both infrastructure and people, partnership and scientific potential.
In the future, collaborative research across disciplines, molecular diagnostics, data medicine, artificial intelligence, advanced biotechnology and clinical decision-making based on research are going to play important roles.
For Sir Ganga Ram Hospital, the challenge lies in combining its own strengths in clinical medicine with an ever-developing ethos of research, teaching and innovation.
The combination of institutional leadership with scientific vision represents a valuable base for this process.
Therefore, the future of healthcare consists of creating institutions where clinical excellence inspires scientific inquiries, and research gives way to innovations.
The commitment of Sir Ganga Ram Hospital is to build upon its best traditions and look into the possibilities that tomorrow’s medicine can bring.
A legacy of excellence. A culture of discovery. A vision for the future of healthcare.
To know more, watch: https://www.youtube.com/watch?v=bcdtI75sQYE
DMC Registration No: 14711
Chairman, Board of Management
Senior Consultant, Department of ENT
Sir Ganga Ram Hospital, New Delhi
Qualifications: MBBS, DLO, MS (ENT) – Maulana Azad Medical College, University of Delhi
(GAB4326)
Associate Professor & Consultant
Department of Biotechnology & Research
Sir Ganga Ram Hospital, New Delhi
Qualifications: PhD, AIIMS (Reg No-5395), Department of Biochemistry, All India Institute of Medical Sciences (AIIMS), New Delhi
